NuVasive Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
685
762
811
962
1,030
1,102
Cost of Goods Sold (COGS) incl. D&A
236
244
207
282
317
362
Gross Income
449
518
604
680
712
740
SG&A Expense
408
452
493
582
590
638
EBIT
41
67
-
98
122
102
Unusual Expense
11
48
30
6
12
51
Non Operating Income/Expense
6
3
2
1
1
5
Interest Expense
27
28
29
41
38
38
Pretax Income
10
11
112
65
74
9
Income Tax
3
6
47
29
7
4
Consolidated Net Income
7
17
65
35
81
12
Net Income
8
17
66
37
83
12
Net Income After Extraordinaries
8
17
66
37
83
12
Net Income Available to Common
8
17
66
37
83
12
EPS (Basic)
0.17
0.36
1.26
0.69
1.50
0.24
Basic Shares Outstanding
44
47
49
50
51
51
EPS (Diluted)
0.17
0.36
1.26
0.69
1.50
0.24
Diluted Shares Outstanding
47
47
52
54
55
52
EBITDA
104
128
177
201
243
232
Non-Operating Interest Income
-
1
1
2
1
1
Minority Interest Expense
1
1
1
2
2
-

About NuVasive

View Profile
Address
7475 Lusk Boulevard
San Diego California 92121
United States
Employees -
Website http://www.nuvasive.com
Updated 07/08/2019
NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. The company was founded by Alexis V.